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Fragile X-associated tremor/ataxia syndrome (FXTAS) is a neurodegenerative disorder
caused by a CGG-repeat expansion in the 5′ UTR of the FMR1 gene on the
X-chromosome. Both elevated levels of the expanded FMR1 mRNA and aberrant
expression of a polyglycine protein (FMRpolyG) from the CGG-repeat region are
hypothesized to trigger the pathogenesis of FXTAS. While increased expression of
FMRpolyG leads to higher toxicity in FXTAS models, the pathogenic effect of this
protein has only been studied in the presence of CGG-containing mRNA. Here we
present a model that allows measurement of the effect of FMRpolyG-expression without
co-expression of the corresponding CGG mRNA hairpin. This allows direct comparison
of the effect of the FMRpolyG protein per se, vs. that of the FMRpolyG protein together
with the CGG mRNA hairpin. Our results show that expression of the FMRpolyG, in
the absence of any CGG mRNA, is sufficient to cause reduced cell viability, lamin
ring disruption and aggregate formation. Furthermore, we found FMRpolyG to be a
long-lived protein degraded primarily by the ubiquitin-proteasome-system. Together, our
data indicate that accumulation of FMRpolyG protein per se may play a major role in the
development of FXTAS.
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INTRODUCTION
Fragile X-associated tremor/ataxia syndrome (FXTAS, #300623) is a neurodegenerative disorder
affecting individuals with a premutation CGG-expansion (55–200 repeats) in the 5′ untranslated
region (UTR) on the Fragile X mental retardation 1 (FMR1) gene on the X-chromosome
(Hagerman et al., 2001). The main clinical features of FXTAS include motor symptoms such as
gait ataxia and intention tremor, often accompanied by Parkinsonism and cognitive impairment
(Hagerman et al., 2001; Jacquemont et al., 2003). The prevalence of the FMR1 premutation causing
FXTAS is 1 in∼290 women and 1 in∼850 men (Hunter et al., 2014), but the penetrance is around
Hoem et al. FMRpolyGly Toxicity Without CGG mRNA
40% in men and 8–16% in women aged over fifty (Jacquemont
et al., 2004; Coffey et al., 2008; Rodriguez-Revenga et al., 2009).
Full-mutation expansions of the FMR1 CGG repeat region
(>200 CGGs) usually result in silencing of the gene and lack of
FMR1mRNA and protein (FMRP). This absence, or very reduced
level of FMRP, is the cause of the neurodevelopmental disorder
Fragile X Syndrome (#300624). Contrary to what is seen upon
the full-mutation, premutation carriers have 2–8-fold increased
levels of FMR1 mRNA (Tassone et al., 2000) and normal or
slightly reduced levels of FMRP (Kenneson et al., 2001). This
increased FMR1-mRNA level, coupled with studies revealing
the presence of the expanded FMR1-mRNA inside intranuclear
inclusions in patient materials (Greco et al., 2002; Tassone et al.,
2004; Iwahashi et al., 2006), led to the development of an
RNA-gain-of-function hypothesis for the FXTAS pathogenesis
(reviewed in Hagerman and Hagerman, 2004). Several studies
have since demonstrated that expression of CGG repeats in the
premutation range leads to features of toxicity and inclusion
formation in both cellular and animal model systems (Jin et al.,
2003; Willemsen et al., 2003; Arocena et al., 2005; Entezam et al.,
2007; Hashem et al., 2009; Hoem et al., 2011; Hukema et al.,
2014). The CGGmRNA forms a strong hairpin structure (Handa
et al., 2003; Zumwalt et al., 2007), but the exact mechanisms by
which the expanded CGG mRNA hairpin induces pathogenic
events, have not been fully elucidated. Among the proposed
pathways are sequestration of specific proteins by the expanded
CGG mRNA hairpin itself (Jin et al., 2007; Sofola et al., 2007;
Sellier et al., 2010, 2013), R-loop formation (Loomis et al., 2014),
and excessive induction of DNA-damage response (Hoem et al.,
2011). A more recently proposed mechanism for the FXTAS-
pathogenesis, is repeat-associated non-AUG (RAN) translation.
RAN translation across microsatellite repeat expansions was
first described by Zu et al. (2011). In 2013 Todd et al. found
that RAN translation also occurs across the expanded CGG
repeat FMR1-mRNA, causing formation of FMRpolyAlanine
and FMRpolyGlycine (FMRpolyG) proteins (Todd et al., 2013).
While conventional translation of the FMR1 mRNA initiates at
an AUG codon downstream of the CGG repeats, RAN translation
starts primarily at a near-cognate start codon (ACG) upstream of
the repeats, thus including the repeat stretch in the translation
product (Todd et al., 2013; Kearse et al., 2016; Sellier et al., 2017).
The resulting aberrant expression of the FMRpolyG protein
from the CGG-expansion appears to have a toxic effect (Todd
et al., 2013). Furthermore, the FMRpolyG protein colocalizes
with the ubiquitin positive intranuclear inclusions found in
FXTAS patients (Todd et al., 2013; Buijsen et al., 2014; Sellier
et al., 2017). Interestingly, Sellier et al. (2017) recently described
a mouse model where they compared expression of expanded
CGG repeats without formation of the RAN-translation product
FMRpolyG, to expression of both the expanded CGG repeats
and the FMRpolyG protein. They clearly demonstrated that
expression of CGG mRNA without formation of FMRpolyG,
resulted in a milder phenotype than that observed when both
components were expressed. In addition, they showed that
expression of the C-terminus of the FMRpolyG protein alone
had a toxic effect in cell culture. However, the consequences
of expressing the entire FMRpolyG protein itself, without
co-expression of the hairpin-forming CGG mRNA, have not
been investigated.
In this study we establish a system allowing expression of
(a) both the FMRpolyG protein and the CGG mRNA hairpin
and (b) the FMRpolyG protein without any CGG mRNA. We
show that expressing the FMRpolyG protein outside the context
of the CGG repeats, and thus without any CGG RNA hairpin,
leads to aggregate formation and cellular toxicity. Furthermore,
FRAP analyses demonstrated that FMRpolyG is completely
immobilized in the aggregates. Finally, we provide evidence for
the FMRpolyG being a long-lived protein degraded through the
ubiquitin-proteasomal system (UPS). This is in line with previous
observations of reduced neurodegeneration upon induction of
the UPS (Oh et al., 2015) and points at the UPS as a potential
target for therapeutic intervention in FXTAS.
RESULTS
Generation of a Construct Expressing
FMRpolyG-GFP Without CGG RNA
Hairpin Formation
While several model systems for FXTAS have shown that
FMRpolyG expression increases toxicity, this has only been
studied in the presence of CGG repeat DNA and RNA (Todd
et al., 2013; Oh et al., 2015; Sellier et al., 2017). A toxic
effect of the entire protein alone has not been demonstrated.
To address this, we constructed a plasmid where the CGG
repeats were replaced by a sequence containing 90 alternative
glycine codons in the +1 frame. Note that the CGGs are read
“GGC” in the +1 reading frame coding for the FMRpolyG
protein. We refer to this region as the CGG repeats, to
point out that we are describing the area of the FMR1-gene
called the “CGG repeat region” in the FXTAS literature. The
complete sequence encoding the FMRpolyG protein without
CGG repeats, was inserted into a plasmid downstream of a CMV-
promoter and in frame with a GFP-tag at the C-terminal end.
The resulting plasmid was named mutatedHairPin-90Glycine-
GFP (mutHP-90Gly-GFP). This was used in parallel with a
plasmid expressing the native RNA hairpin-forming CGG repeat
sequence (Sellier et al., 2017), here called wildtypeHairPin-
99Glycine-GFP (wtHP-99Gly-GFP) (Figure 1A). ATG start
codons were inserted to ensure expression from both constructs.
With the exception of intended substitution of the CGG repeats,
the FMRpolyG encoding sequences are identical in both plasmids
(Supplementary Figure 1A). The wtHP-99Gly-GFP construct
has already been demonstrated to cause features of FXTAS in cell
culture (Sellier et al., 2017).
To determine the potential of the mutHP-90Gly to form
an RNA hairpin structure, the polyG-sequences of both
mutHP-90Gly and wtHP-99Gly were analyzed using the
bioinformatic tools RNAfold (http://rna.tbi.univie.ac.at/cgi-
bin/RNAWebSuite/RNAfold.cgi) and RNAstructure (https://
rna.urmc.rochester.edu/RNAstructureWeb/Servers/Predict1/
Predict1.html). The wtHP-99Gly has a strong potential to form
a hairpin structure, while this is not the case for mutHP-90Gly
(Supplementary Figure 2). Not only is the predicted secondary
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FIGURE 1 | The FMRpolyG protein itself causes aggregate formation in several cell lines. (A) Schematic representation of the wtHP-99Gly-GFP and
mutHP-90Gly-GFP constructs used in this study. Both contain the part of the FMR1 5′UTR that encodes the entire FMRpolyG protein (shown in blue). The
wtHP-99Gly-GFP construct gives rise to both a CGG RNA hairpin and the FMRpolyGlycine protein. In mutHP-90Gly-GFP, the CGGs have been substituted with
alternative glycine codons to abolish hairpin formation. (B) Confocal images of GFP-positive aggregates in the indicated cell lines, transfected with wtHP-99Gly-GFP
or mutHP-90Gly-GFP and analyzed 24–48 h after transfection. (C,D) Quantification of FMRpolyG-GFP aggregates in HEK293 cells 24 h after transfection, presented
as number of aggregates per 100 cells (C) or 100 GFP-positive cells (D). Untransfected cells and cells transfected with GFP-C1 were used as negative controls. Small
aggregates range from 1 to 3 µm2 in size, while large aggregates are those over 3 µm2. Calculations are based on three individual experiments, each including
>4,500 cells for each plasmid. Error bars represent standard deviation (SD).
structure vastly different between the two, but the free energy and
the frequency of the minimal free energy (MFE) structures varies
by >40-fold between them, with the CGG RNA hairpin from the
wtHP-99Gly-construct standing out as the only stable secondary
structure. While such predictions provide some information
as to what the expected structure could be, it is important to
keep in mind that they are not sufficient to completely exclude
secondary structures formed by the mRNA. It is beyond the
scope of this paper to determine the exact secondary structure of
these mRNAs. However, since all the bioinformatic prediction
tools show that the CGG-mRNA forms a stable hairpin, while
the GGN-mRNA does not, we concluded that the latter forms a
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different and less stable secondary structure. Since the mutHP-
90Gly sequence does not contain the CGGs, it cannot form
a CGG-hairpin.
Sellier et al. (2017) have demonstrated that expression of
the FMRpolyG protein together with the CGG RNA hairpin
causes aggregate formation in both a mouse model system,
neuronal cell lines and HEK293 cells. We first confirmed
the results by transiently transfecting HEK293 cells with the
same plasmid as used by Sellier et al., namely wtHP-99Gly-
GFP. Next, we tested whether the mutHP-90Gly-GFP–plasmid
was able to induce aggregate formation in cells. Importantly,
aggregate formation was detected not only in cells transfected
with wtHP-99Gly-GFP, but also in those transfected withmutHP-
90Gly-GFP (Figure 1B). In addition, both constructs induced
aggregate formation in different cell lines, including HeLa, COS7,
and neuronal SH-SY5Y cells (Figure 1B). This demonstrates
that the FMRpolyG protein alone, without co-expression of
the CGG RNA hairpin, can give rise to aggregates in various
cell lines.
The wtHP-99Gly-GFP Construct Gives
Many Fold Higher Protein Expression
Levels Than the mutHP-90-Gly-GFP
Construct
Interestingly, we found both the size and number of aggregates,
and number of cells expressing detectable levels of the GFP-
tagged FMRpolyG protein, to be several folds higher in
cells transfected with wtHP-99Gly-GFP, compared to those
transfected with mutHP-90Gly-GFP. We quantified the
number of aggregates both relative to the total number of
cells, and to the number of GFP-positive cells visualized by
confocal microscopy. To avoid overexposure of GFP-positive
aggregates during confocal microscopy, settings resulted
in a high threshold of GFP-intensity required to count a
cell as GFP-positive. The threshold is the same for wtHP-
99Gly-GFP and mutHP-90Gly-GFP expressing cells. The
number of aggregates per 100 total cells is ∼30-fold higher
in wtHP-99Gly-GFP than in mutHP-90Gly-GFP expressing
cells (Figure 1C). This ratio is reduced to just ∼1.8-fold
when comparing only the GFP-positive cells (Figure 1D).
Hence, the elevated protein-expression levels of wtHP-
99Gly-GFP compared to mutHP-90Gly-GFP may explain
the increased aggregate formation in cells transfected with
wtHP-99Gly-GFP. Importantly, aggregate formation was
also seen sporadically upon expression of both constructs
when the ATG is replaced with the native ACG-codon
(Supplementary Figures 2B,C).
The mutHP-90Gly-GFP construct used in this study,
contained an around 100 nt insertion 5′ to the polyGly
ATG start-codon (Supplementary Figure 1A). To elucidate
if these inserted nucleotides had any impact on the rate
of transcription/translation, a new construct with a 5′
region identical to the wtHP-99Gly-GFP was established
(Supplementary Figure 1B). We assessed the aggregate
formation and FMRpolyG mRNA levels in the cells expressing
this new construct (Supplementary Figure 3). Importantly,
removal of the around 100 nucleotides insertion did
not affect aggregate formation or the FMRpolyG mRNA
levels, clearly indicating that this insertion had no impact
on the expression from the mutHP-90Gly-GFP construct
(Supplementary Figure 3).
Next, we established two Flp-In-T-REx 293 (HEK-FlpIn) cell
lines with inducible expression of wtHP-99Gly-GFP or mutHP-
90Gly-GFP, respectively. Induction of FMRpolyG expression
in these cells demonstrated the same pattern with higher
levels of GFP-positive cells and more cells with aggregates
in the wtHP-99Gly-GFP cells compared to the mutHP-
90Gly-GFP cells. This prompted us to monitor more closely
the FMRpolyG-GFP protein levels in the two different cell
populations. We first performed flow analyses on the two
HEK-FlpIn cell lines, 24 h after expression was induced.
For both cell lines, around 90% of the cells were GFP-
positive (Figures 2A,B), indicating that there is no difference
in the portion of cells expressing the GFP-tagged protein.
However, the GFP fluorescence intensity of the wtHP-99Gly-
GFP expressing cells was around 5-fold higher than in the
GFP fluorescence intensity of the mutHP-99Gly-GFP cells
(Figures 2A–C). To verify if the GFP fluorescence intensity
pictured the expression level of the FMRpolyG protein, GFP-
positive cells from both cell lines were sorted and harvested,
and the FMRpolyG protein levels quantitated by Western
blotting (Figures 2D,E). In line with the flow and imaging
analyses, wtHP-99Gly-GFP-expressing cells demonstrated ∼10-
fold higher FMRpolyG protein levels compared to mutHP-GFP
expressing cells (Figure 2D).
To investigate if the enhanced protein expression from the
wtHP-99Gly-GFP expressing cells is due to enhanced wtHP-
99Gly-GFP mRNA levels, FMRpolyG-GFP-protein and mRNA
levels were quantitated both in transiently transfected and
in the induced HEK-FlpIn cells (Supplementary Figure 4).
qPCR analyses performed on RNA from cells harvested
24 h post transfection with either construct, revealed ∼ 22
times more GFP-mRNA in cells transfected with wtHP-
99Gly-GFP, compared to those transfected with mutHP-90Gly-
GFP (Supplementary Figure 4A). Furthermore, the FMRpolyG
protein levels measured by Western blot was ∼5-fold higher
in wtHP-99Gly-GFP cells than in mutHP-90-Gly-GFP cells
(Supplementary Figures 4B,C). For the induced HEK-FlpIn cell
lines, levels of GFP-mRNA and FMRpolyG protein (measured
by Western blot) were, respectively, ∼11 and 13-folds higher
for the cell line expressing wtHP-99GGC-GFP than the cell line
expressing mutHP-90Gly-GFP (Supplementary Figures 4D–F).
In total, these results show that the wtHP-99Gly-GFP expression
construct leads to several fold higher mRNA and protein
levels compared to the mutHP-90Gly-GFP expression construct,
even when the same number of cells are expressing each
construct. This could point toward the RNA hairpin being
important for high levels of FMRpolyG mRNA, leading to
high level of protein expression and aggregate formation.
Importantly, the capacity for aggregate formation apparently
directly correlates with the expression level of the FMRpolyG
protein, though there is no evidence that this correlation
is linear.
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FIGURE 2 | Expression of wtHP-99Gly-GFP results in several fold higher protein levels than that of mutHP-90-Gly-GFP expression. (A,B) Merge of flow curves
showing the differences in GFP fluorescence intensity in HEK-FlpIn cells expressing no GFP-tagged protein (negative control, purple), mutHP-90Gly-GFP (blue) and
wtHP-99Gly-GFP (green). Flow analysis and sorting was performed separately on each cell population 24 h after induction of expression. Note the logarithmic scale on
the X-axis. GFP-positive cells expressing wtHP-99Gly-GFP were sorted into gate P3. GFP-positive cells expressing mutHP-90Gly-GFP were sorted into gate P2. (C)
The graph demonstrates the large difference in mean fluorescence (GFP) intensity between mutHP-90Gly-GFP and wtHP-99Gly-GFP expressing cells. (D) The graph
shows the difference in FMRpolyG-GFP protein levels in HEK-FlpIn cells stably expression mutHP-90Gly-GFP and wtHP-99Gly-GFP. The cells were sorted using flow
with the gates illustrated in (A,B). For mutHP-90Gly-GFP cells expressing GFP-levels above the threshold in gate P2 were included, while wtHP-99Gly-GFP
expressing cells included are those above the threshold in gate P3. The graph is based on WB-quantification of sorted cells from the two above mentioned cell
populations. (E) Western blot of sorted cells expressing wtHP-99Gly-GFP or mutHP-90Gly-GFP. Protein levels of wtHP-99Gly-GFP expressing cell is set to 1 in each
experiment. Data in A-D is based on three independent experiments were cells were subject to flow, sorted and lysed 24 h after expression was induced.
Transient Transfection and Stable
Expression of wtHP-99Gly-GFP and
mutHP-90Gly-GFP Result in Similar
Kinetics of FMRpolyG-GFP Aggregate
Formation
Despite differences in mRNA levels and protein levels during
both transient transfections and stable expression, both
wtHP-99Gly-GFP and mutHP-90Gly-GFP expression led to
aggregate formation in all cell lines tested.
In order to determine whether the wt and mutated construct
has similar capacity to form aggregate over time, cells were
fixed at 24, 48, and 72 h after transfection. Although wtHP-
99Gly-GFP resulted in the highest number of aggregates and
GFP-positive cells at every time point, the two constructs
displayed similar aggregation kinetics (Figures 3A,B). Notably,
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aggregates were detected already 7 h after transfection for the
wtHP-99Gly-GFP construct, and after 15 h for cells transfected
with mutHP-90Gly-GFP (Supplementary Videos 1, 2).
Next, aggregate formation was analyzed by time-course
experiments in the inducible HEK-FlpIn cell lines. Cells were
fixed and imaged 24-, 48-, and 72 h after induction. Similar to
the transient transfections, the highest number of aggregates was
observed in wtHP-99Gly-GFP-expressing cells, at all time-points
(Figures 3C–E). However, the pattern of increasing aggregate
formation over time is the same for the two cell lines. In
conclusion, both during transient transfection and upon stable
expression, the wtHP-99Gly-GFP construct results in more
mRNA, more FMRpolyG-GFP protein and a stronger capacity
for aggregate formation, at all time points. This supports the
notion that the CGG hairpin increases expression or stability of
its own mRNA, and thus the amount of FMRpolyG expressed
in cells. However, here we demonstrate that also a low, stable
expression of the FMRpolyG protein, without a co-expressed
CGG mRNA hairpin, has the ability to form aggregates in
cells. Interestingly, despite the difference in absolute numbers
of aggregates, the pattern of increasing aggregate formation
over time is very similar whether cells express wtHP-99Gly-GFP
or mutHP-90Gly-GFP.
The FMRpolyG Protein Expression Induces
Formation of Intranuclear Aggregates
The neuropathological hallmark of FXTAS is the presence of
intranuclear aggregates in both the CNS and peripheral tissues
(Greco et al., 2002; Hunsaker et al., 2011). Formation of
intranuclear aggregates by expression from the wtHP-99Gly-
containing construct, has already been demonstrated (Sellier
et al., 2017). In order to determine whether this was also
the case for mutHP-90Gly-GFP, we used confocal microscopy
to identify aggregates in cells transfected with either wtHP-
99Gly-GFP or mutHP-90Gly-GFP. Importantly, the mutHP-
90Gly-GFP construct lead to formation of the same portion of
intranuclear aggregates as the wtHP-99Gly-GFP construct. We
observed that around 10–15% of aggregates were intranuclear
24 h after transfection (Figures 4A,B). This clearly demonstrates
that mutHP-90Gly has a similar potential as wtHP-99Gly to
form intranuclear aggregates. Hence, this feature seems to be
independent of the CGG mRNA hairpin.
The FMRpolyG Protein Reduces Cell
Viability and Disrupts the
Lamin Architecture
Another important histopathological finding in FXTAS patients
is the loss of both neuronal and glia cells (Greco et al.,
2006). Accordingly, expression of the FMR1-5′UTR including a
premutation, has been proven to cause cell death in cultured
cells and animal models (Jin et al., 2003; Arocena et al., 2005;
Entezam et al., 2007; Hoem et al., 2011). We sought to answer
whether expression of the mutHP-90Gly-GFP construct causes
cell death. For this purpose, the effect of the FMRpolyG protein
on cell viability was assessed by flow cytometry of cells transiently
transfected with the wtHP and mutHP constructs in parallel with
the vector control GFP-C1. Loss of viability was determined by
quantifying the portion of GFP-positive cells which incorporated
propidium iodide (PI). Interestingly, we saw no difference in
cell viability for the cells expressing FMRpolyG-GFP and RNA
hairpin, vs. those only expressing the FMRpolyG-GFP protein
(Figure 5A). At 24 h post transfection they both demonstrated
∼8% reduction in cell viability, compared to 4% in the GFP-
C1-positive control population (Figure 5A). These findings point
toward a toxic effect mediated by the FMRpolyG protein,
independent from the CGG RNA hairpin formation per se.
In several model systems for FXTAS, abnormal lamin ring
structure in the presence of FMR1 5′UTR with the CGG-
expansion has been reported (Arocena et al., 2005; Hoem et al.,
2011; Sellier et al., 2017). Lamin is also present in inclusion
bodies present in tissues from FXTAS-patients (Iwahashi et al.,
2006). We therefore asked whether the FMRpolyG protein,
in the absence of a CGG mRNA hairpin, would affect lamin
architecture. To answer this, cells were transfected with wtHP-
99Gly-GFP or mutHP-90Gly-GFP, fixed 24 h later and stained
with lamin B1 antibody. The number of disrupted lamin rings
were quantified in GFP-positive cells and aggregate-bearing
cells (Figure 5B). Clearly, there is a strong correlation between
the expression of FMRpolyG and observation of disrupted
lamin rings, with FMRpolyG-GFP positive cells demonstrating
a significant higher portion of abnormal lamin rings compared
to GFP-C1 positive controls (Figures 5B,C). Furthermore, cells
stably expressing the FMRpolyG protein plus the RNA hairpin
did not have a higher portion of disrupted lamin rings compared
to those expressing the FMRpolyG protein only.
A similar pattern of lamin ring disruption was observed in
HEK-FlpIn cells stably expressing wtHP-99Gly-GFP or mutHP-
90Gly-GFP for 72 h. The control was a HEK-FlpIn-GFP-C1 cell
line previously described (Larsen et al., 2010) (Figures 5D,E).
This demonstrates that the FMRpolyG protein itself is sufficient
to impair the lamin structure in cells.
FMRpolyG Is Immobilized in Aggregates
and These Structures Do Not Co-localize
With the Microtubule Organizing
Center (MTOC)
Having observed that expression of the FMRpolyG protein
alone reduced cell viability, disrupted lamin architecture and
formed intranuclear aggregates, we next investigated the protein’s
mobility in the cell. For this purpose, we applied FRAP
(Fluorescence Recovery After Photobleaching) on live cells
and studied both the diffuse cytosolic and nuclear portion of
the protein, and the aggregate-located portion. We compared
the FMRpolyG-GFP expression constructs to GFP-tagged p62.
The p62 protein is a well-characterized receptor for selective
autophagy (reviewed in Lamark et al., 2009; Khaminets
et al., 2016), which has been demonstrated to become quite
immobilized in large p62 bodies (Matsumoto et al., 2011).
Furthermore, its diffuse soluble fraction is mobile, even though
it does to some extent form complexes (Kraft et al., 2016). The
p62-protein and its properties has been well-characterized in
our lab, and it thus serves as a good reference protein. The
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FIGURE 3 | Both transient transfection and stable expression of wtHP-99Gly-GFP and mutHP-90Gly-GFP results in a similar kinetics of FMRpolyG-GFP aggregate
formation. (A) Representative confocal images of transfected HEK293 cells, displaying aggregate formation 24, 48, and 72 h after transfection with either
wtHP-99Gly-GFP (upper panel) or mutHP-90Gly-GFP (lower panel). Untransfected cells and cells transfected with GFP-C1 were used as negative controls. (B)
Quantification of FMRpolyG-GFP aggregates formed 24, 48, and 72 h after transfection. (C) Confocal images of FMRpolyG-GFP aggregate formation in HEK-FlpIn
cells stably expressing wtHP-99Gly-GFP (upper panel) or mutHP-90Gly-GFP (lower panel) from a tetracycline-inducible promoter. Doxycycline was added 24, 48, or
72 h prior to fixation. (D,E) Quantification of FMRpolyG-GFP aggregates formed in experiments shown in (B). Error bars in (B,D,E) represent SD of averages from a
minimum of three independent experiments.
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FIGURE 4 | The FMRpolyG protein expression induces formation of intranuclear aggregates. (A) Representative confocal images of intranuclear aggregates in
HEK293 cells transfected with wtHP-99Gly-GFP (upper panel) or mutHP-90Gly-GFP (lower panel). Untransfected cells and cells transfected with GFP-C1 were used
as negative controls. (B) Quantification of aggregates that are intranuclear 24 h post transfection. The graphs represent the percentage of aggregates that are
intranuclear, based on three individual experiments, each including a minimum of 45 aggregates per construct.
FRAP-assay revealed that the fraction of GFP-tagged FMRpolyG
protein which is mobile (replaced after photobleaching), is
high (>75%) when it appears as diffuse in the cytosol or the
nucleus, but very low (<10–20%) in the aggregates (Figure 6A).
Importantly, the mobility of these fractions does not differ
between wtHP-99Gly-GFP and mutHP-90Gly-GFP, indicating
that the dynamics of FMRpolyG is not affected by the CGG
mRNA hairpin. In addition, the fractions of GFP-tagged protein
which are mobile, are strikingly similar for FMRpolyG and
p62. Given p62’s known tendency to form aggregates, it is
likely that the FMRpolyG protein can behave in a similar way.
To conclude, the FRAP-results demonstrate that FMRpolyG
is mobile in both the cytoplasmic and nuclear compartments
of the cell, but its localization to aggregates affects these
dynamics and renders the protein immobile. Importantly, the
dynamics of the FMRpolyG protein are independent of the CGG
mRNA hairpin.
Next, we asked whether the aggregates themselves were
mobile and traveled along microtubuli. To measure this,
we quantified co-localization between the microtubule
organizing center (MTOC) and the aggregates. No significant
co-localization was observed (Figures 6B,C). Moreover,
treatment with the microtubule inhibitor nocodazole, did
not prevent formation of aggregates (data not shown).
Due to the highly toxic effect of long-term nocodazole
treatment, we were not able to quantify number of aggregates
in this population compared to untreated controls, but
aggregates clearly formed in all transfected cell populations.
The lack of co-localization with MTOC together with
nocodazole’s inability to prevent aggregate formation,
point toward a microtubule-independent formation of
aggregates. Thus, the structures are not classical aggresomes
(reviewed in Kopito, 2000).
FMRpolyG Forms Dense
Filamentous Aggregates
FXTAS inclusions have been examined by electron microscopy
and described by both Greco et al. (2002) and Gokden
et al. (2009), as compact and granulofilamentous. In order
to determine the ultrastructure of the aggregates formed in
the cellular systems described here, we performed CLEM
(Correlative Light and Electron Microscopy) analyses of
both mutHP-90Gly-GFP and wtHP-99Gly-GFP generated
aggregates (Figures 7A–L). The ultrastructure of these
aggregates was compared to that of aggregates formed by
GFP-p62. p62 aggregates have been subjected to CLEM/EM
and described as electron dense and with a filamentous
appearance (Bjorkoy et al., 2005; Paine et al., 2005; Filimonenko
et al., 2007; Nezis et al., 2008; Sukseree et al., 2018).
Figures 7M–O show a GFP-p62 aggregate presenting this
morphology. Both wtHP-99Gly-GFP and mutHP-90Gly-
GFP form dense, filamentous aggregates (Figures 7A–L).
The filamentous nature of the aggregates was clearly
seen on EM tomography of a wtHP-99Gly-GFP aggregate
(Supplementary Video 3). Some of the larger aggregates,
primarily seen in wtHP-99Gly-GFP-expressing cells, appear
very dense and symmetric, with a center that is brighter
(Figure 7F), likely due to incomplete penetration of the
heavy metal contrast agents used. Interestingly, some of
the mutHP-90Gly-GFP-aggregates are less dense and more
granular (Figure 7L). These may represent an earlier, less
protein-rich stage of the same aggregates or a different
form of aggregates. Notably, these aggregates are generally
smaller than the very dense ones. In concordance with
observations by Greco et al. (2002) and Gokden et al. (2009),
we generally did not see any membrane surrounding the
entire aggregates.
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FIGURE 5 | The FMRpolyG protein reduces cell viability and disrupts the lamin architecture. (A) Effect of FMRpolyG on cell viability. HEK293 cells were transfected
with the indicated constructs, and cell death measured in GFP positive cells. Cell transfected with GFP-C1 were used as negative controls. Cells were counted as
non-viable based on the incorporation of propidium iodide detected by FACS. For each transfection >50 000 cells were counted per experiment. ***p < 0.001; **p <
0.01; *p < 0.05. The exact p-values, from left to right, are as follows: 0.0009 and 0.0081. (B) Effect of FMRpolyG on lamin architecture. HEK293 cells were
transfected with the indicated constructs and stained for Lamin B1 24 h after transfection. Transfection with GFP-C1 served as negative control. Cells were analyzed
by confocal imaging, and the fraction of cells with disrupted lamin architecture counted in GFP positive cells (left) and in cells with aggregates (right). The number of
GFP positive cells included in the analysis was >440 for GFP-C1 and wtHP-99Gly-GFP. For wtHP-99Gly-GFP > 170 aggregate bearing cells were counted. Due to
the low levels of GFP positive cells among those transfected with mutHP-90Gly-GFP, a total of 80 GFP-positive cells and 70 aggregate bearing cells were included
from mutHP-90Gly-GFP transfected cell populations. The exact p-values, from left to right, are as follows: 0.0021 (**), 0.0004 (***), 0.0123 (*), and 0.0113 (*). (C)
Representative confocal images showing normal lamin rings in cells expressing GFP (GFP-C1), but disrupted lamin architecture in aggregate-containing cells after
transfection of wtHP-99Gly-GFP or mutHP-90Gly-GFP. (D) Effect of stably expressed FMRpolyG on lamin architecture. Expression of GFP or FMRpolyG-GFP were
induced with doxycycline for 72 h, followed by Lamin B1 staining, confocal imaging, and counting of GFP positive cells with disrupted lamin architecture. Cell
expressing GFP (from GFP-C1) were used as negative controls. For GFP-C1 and wtHP-99Gly-GFP, a minimum of 830 GFP positive cells were quantified. Due to low
expression levels in cells expressing mutHP-90Gly-GFP, 150 GFP-positive cells were included for this construct. For wtHP-99Gly-GFP and mutHP-90Gly-GFP, a
minimum of 80 aggregate bearing cells were analyzed per construct. The exact p-values, from left to right, are as follows: 0.0186 (*), 0.0007 (***), 0.00001 (***), and
0.0004 (***). (E) Representative confocal images showing normal lamin rings in HEK-FlpIn cells expressing GFP and disrupted lamin structures in aggregate-containing
cells expressing FMRpolyG-GFP. All graphs in (A,B,D) are based on quantifications of a minimum of three individual experiments and error bars represent SD.
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FIGURE 6 | FMRpolyG is immobilized in aggregates and these structures do not co-localize with the microtubule organizing center (MTOC). (A) FMRpolyG-GFP is
immobile in aggregates. Mobility of FMRpolyG-GFP and GFP-p62 in aggregates and diffuse fractions were analyzed by fluorescence recovery after photobleaching
(FRAP). The mobile fractions were calculated using the ZEN 2012 (black edition) software. FMRpolyG-GFP was compared to GFP-p62 known to become immobilized
in aggregates. GFP-p62 thus served as a positive control for immobilization in aggregates. Averages are based on a minimum of 8 nuclear foci, 12 cytoplasmic foci,
and 12 aggregates for each construct. (B) Fraction of FMRpolyG-GFP positive aggregates that co-localize with MTOC. Counting is based on confocal images. The
graphs represent three independent experiments, and >60 aggregates per construct. (C) Representative confocal image of HEK293 cell with FMRpolyG-GFP
aggregates, none of which co-localize with MTOC (red dots). Cells were stained with anti-γ-tubulin antibody to visualize MTOC. Error bars in (A,B) represent SD.
Proteasomes Are Recruited to
FMRpolyG Aggregates
Here we have shown that the FMRpolyG protein, even in the
absence of a CGG RNA hairpin, forms dense aggregates and has
a toxic effect on cells. Degradation of proteins that are misfolded,
toxic or for other reasons labeled as unwanted by the cell,
is carried out by autophagy and/or the ubiquitin-proteasomal
system (UPS). Studies performed in a Drosophila model for
FXTAS have demonstrated that inhibition of UPS increases
neurodegeneration, while inhibiting autophagy can improve the
phenotype (Oh et al., 2015). Moreover, mayor players in the
UPS, namely ubiquitin and the proteasome, are present in FXTAS
inclusions (Iwahashi et al., 2006; Lin et al., 2013). With this
in mind, we asked whether protein components of the UPS
and/or the autophagy machinery co-localized with FMRpolyG-
aggregates in our system. For this purpose, cells containing
FMRpolyG aggregates were stained with antibodies to marker
proteins for UPS (20S proteasome and ubiquitin) and autophagy
(LC3B and p62), and analyzed by fluorescence confocal
microscopy. The majority of aggregates contained both ubiquitin
and the 20S proteasome (Figures 8A–C). Interestingly, p62, an
autophagy receptor involved in both autophagic and proteasomal
degradation of proteins (Pankiv et al., 2007; Geetha et al., 2008),
was enriched in ∼35–50% of the aggregates (Figures 8A,D).
p62 has previously been found in FXTAS-inclusions (De Pablo-
Fernandez et al., 2015). In contrast, LC3B, a major adaptor
and marker in the autophagy pathway, was not found to be
present in the aggregates (Figure 8E). Importantly, we find the
numbers of p62-, proteasome-, and ubiquitin positive aggregates
to be similar in wtHP-99Gly-GFP and mutHP-90Gly-GFP
expressing cells.
Degradation of the FMRpolyG Protein Is a
Slow Process Impeded by UPS Inhibition
The presence of ubiquitin and the 20S proteasome in FMRpolyG
aggregates, prompted us to investigate how the FMRpolyG
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FIGURE 7 | FMRpolyG forms dense filamentous aggregates. Cells expressing GFP-tagged FMRpolyG were fixed and imaged by confocal microscopy to localize
aggregate-containing cells, and subsequently processed for transmission electron microscopy. Following ultramicrotomy, cells of interest were relocalized within
sections and imaged at both intermediate and high magnifications to analyze the surrounding cellular environment and ultrastructural details of the aggregates,
respectively. Transmission electron micrographs of boxed areas in confocal images (A,D,G,J,M) are shown at intermediate (B,E,H,K,N) and high (C,F,I,L,O)
magnification. Arrow heads indicate the position of aggregates inside cells. (A–F) wtHP-99Gly-GFP aggregates consist of filaments that can be found in parallel
orientation to the plane of sectioning over significant lengths (>100 nm), and that lay in close vicinity to the nucleus and to annulate lamellae in ultrathin sections. Note
decreased staining toward the center of a large aggregate (F). (H–L) mutHP-90Gly-GFP aggregates are similar to wtHP-99Gly-GFP aggregates but appear less
densely packed and displayed uniform staining throughout the aggregates in all observed cases. A subset of mutHP-90Gly-GFP aggregates show a highly repetitive
pattern of low-contrast spots circularly arranged around a central spot of slightly larger size and higher contrast (L). (N,O) In comparison to FMRpolyG aggregates,
GFP-p62 aggregates appear to consist of thinner filaments that radiate in all directions within the plane of sectioning. Scale bars are 5µm (A,D,G,J,M), 2µm
(B,E,H,K,N), and 500 nm (C,F,I,L,O). n, nucleus; al, annulate lamellae; pm, plasma membrane; m, mitochondria. Red spheres in (J,M) are fiducial beads used for
image registration.
protein is degraded. Since the FMRpolyG protein has
demonstrated the same tendency to form aggregates, cause
cellular toxicity, has the same mobility, and co-localizes with
the same proteins whether it is produced from wtHP-99Gly-
GFP or mutHP-90Gly-GFP, we chose the HEK-FlpIn cell
line with the highest expression of the FMRpolyG protein
(wtHP-99Gly-GFP) for degradation studies. Using a flow-
based assay, we monitored GFP-fluorescence in a “tet-on-off”
experiment. In parallel, we followed the degradation of GFP-p62
in a HEK-FlpIn cell line (Larsen et al., 2010). The GFP-p62-
protein has a half-life of ∼14 h in full medium in HEK cells
(Larsen et al., 2010), and is degraded through autophagy
(Bjorkoy et al., 2005; Pankiv et al., 2007).
By adding tetracycline, expression of GFP-fusion proteins
in the cells was first induced for 48 h, followed by 12, 24, or
48 h in tet-free medium (tet-off). This allows monitoring of
how the GFP-tagged FMRpolyG protein-levels decrease when
expression is turned off. In parallel, cells were treated with either
the proteasomal inhibitor MG132, or the lysosomal inhibitor
Bafilomycin A1 (BAF A1). GFP-p62-levels were reduced by
more than 70% after 48 h with tet-off. As expected, GFP-p62
accumulated upon BAF-A1 treatment, while its levels were
unaltered by inhibiting the proteasome with MG132 (Figure 8F).
In contrast, FMRpolyG was degraded slowly, with barely a
30% reduction of GFP-levels after 48 h with tet-off (Figure 8G).
Furthermore, FMRpolyG-levels increased upon inhibition of the
proteasome, while treatment with the lysosomal inhibitor had
a minor impact (Figure 8H). These observations indicate that
FMRpolyG is a very stable protein which is degraded primarily
through the UPS. The results are consistent with a model where
very low expression levels of FMRpolyG can accumulate over
time and cause toxicity late in life.
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FIGURE 8 | Proteasomes are recruited to FMRpolyG aggregates. (A) Representative confocal fluorescence microscopy images of HEK293 cells transfected with
wtHP-99Gly-GFP (upper panel) or mutHP-90Gly-GFP (lower panel) and immunostained with antibodies to the proteasome, ubiquitin and p62. Fraction of
FMRpolyG-GFP aggregates which co-localized with the proteasome (B), ubiquitin (C), p62 (D), or LC3B (E), after transfection of wtHP-99Gly-GFP (black bars) or
mutHP-90Gly-GFP (white bars). Cells were stained for the indicated endogenous proteins. Quantifications were performed using the image analyzing software
Volocity, and are based on 3–6 experiments. For (B) the total number of aggregates included in the quantification was >65 per construct. The remaining graphs (C–E)
are based on analysis of a total of > 190 GFP-positive aggregates per construct. (F–H) FMRpolyG is mainly degraded by the proteasome. Except for the negative
controls (uninduced cells), HEK-FlpIn cells were treated with tetracycline (1µg/ml) for 48 h to induce accumulation of GFP-p62 (F) or FMRpolyG-GFP (G,H),
respectively. Degradation was then measured by flow cytometry of the entire cell population (>20,000 cells for each condition, per experiment), as a loss in mean GFP
intensity after the removal of tetracycline (Tet Off). The experiments were performed as indicated in the absence or presence of Baf-A1 or MG132. All graphs are
based on a minimum of three independent experiments. The exact p-values in (F) are 0.67 (for the n.s. difference), and 0.006 (for difference marked by two stars). The
exact p-values, from left to right, in (H) are as follows: 0.029 (one star), 0.402 (n.s.), 0.048 (one star), and 0.933 (n.s.). Error bars represent SD.
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DISCUSSION
Numerous studies have demonstrated a toxic effect by expressing
mRNA harboring an expanded CGG repeat sequence (Jin et al.,
2003; Willemsen et al., 2003; Arocena et al., 2005; Entezam
et al., 2007; Hashem et al., 2009; Hoem et al., 2011; Hukema
et al., 2014). The finding of RAN-translation from the expanded
CGGs (Todd et al., 2013), hypothesized that the RAN-translation
product FMRpolyG contributes to this toxicity. Sellier et al.
(2017) have recently shown that expression of the FMRpolyG
protein together with the CGG mRNA hairpin, is more toxic
than expressing the CGG mRNA alone, and that the C-terminal
end of FMRpolyG reduces cell viability when expressed without
the remaining protein sequence. Previous studies have not
investigated the effects of expressing the complete FMRpolyG
protein without the CGG mRNA hairpin.
We have established a cellular model where the FMRpolyG
protein is expressed without the corresponding CGG mRNA
hairpin. This allows analyses of the effects mediated by the
FMRpolyG protein without any CGG mRNA. Using this system,
we are, to our knowledge, the first to show that the complete
FMRpolyG protein causes aggregate formation across several
cell lines, forms intranuclear aggregates, reduces cell viability
and disrupts the architecture of lamin rings, in the absence of
CGGmRNA. Furthermore, expression of the FMRpolyG protein
together with the native RNA-hairpin-forming CGG repeats did
not increase features of cellular toxicity such as cell death or lamin
ring disruption, compared to that observed with the FMRpolyG
translated from mRNA without CGG repeats.
Notably, a parallel can be drawn to studies of RAN-translated
dipeptide repeat proteins (DRPs) arising from the chromosome
9 open reading frame 72 (C9ORF72) G4C2-expansion causing
amyotrophic lateral sclerosis and frontotemporal dementia (ALS-
FTD, #105550). Expression of synthetic DRPs where the G4C2
repeats have been substituted by alternative codons for the same
peptide sequence, results in toxicity and aggregate formation
(May et al., 2014; Mizielinska et al., 2014; Yamakawa et al., 2015).
This, together with findings both in the current study and by
Sellier et al. (2017), suggest that toxicity mediated by expression
of the peptide sequence of RAN translated proteins is a general
mechanism that may occur in several repeat associated disorders.
In our model, substituting the CGG repeats with alternative
codons for the polyGlycine stretch in the FMRpolyG protein,
resulted in a several-fold reduced expression of both mRNA and
protein from the gene. This supports an already proposed cis-
acting effect on transcription mediated by the CGGs themselves
(Chen et al., 2003). Because GGC is the most frequently used
glycine codon, we cannot exclude that the change into less
common glycine codons, contribute to the low expression from
the muHP construct by reducing translation efficiency. However,
there is also much less mRNA produced from the mutHP
construct, supporting that the main difference is at the level
of transcription. It is well-known that the FMR1 mRNA levels
in PM carriers are 2–8-folds higher than observed for non-
expanded alleles (Tassone et al., 2000). This is close to the
∼11-fold difference we observed between the wtHP-99Gly-GFP
and the mutHP-90Gly-GFP mRNA levels we observed in the
HEK-FlpIn cell lines. Elevated mRNA levels from expanded
alleles are also found in mice (Entezam et al., 2007; Brouwer
et al., 2008) and upon transient transfection of HEK293 cells
(Chen et al., 2003). The reason for the elevatedmRNA levels from
premutation alleles appears to be increased transcription rather
than mRNA stability (Tassone et al., 2007).
Our findings show that FMRpolyG, in the absence of CGG
mRNA, causes both cell death and lamin ring disruption, two
important features of cellular toxicity observed in previousmodel
systems for FXTAS (Arocena et al., 2005; Hoem et al., 2011;
Sellier et al., 2017). This is consistent with Sellier et al.’s (2017)
observations that the C-terminal end of the FMRpolyG was
required for lamin ring disruption and played an important role
in reducing cell viability. However, toxicity is also observed in
a mouse model for FXTAS where the FMRpolyG protein is not
expressed (Entezam et al., 2007; Todd et al., 2013). This suggests
that the CGG mRNA has an independent toxic effect that does
not rely on FMRpolyG expression. In our study, we do not find
increased toxicity for FMRpolyG plus CGG mRNA compared
to FMRpolyG alone, but the CGGs have a strong impact on
the expression level of the FMRpolyG. A toxic effect of the
FMRpolyG protein can thus be interpreted as further evidence
for the CGG’s importance in triggering FXTAS.
The C-terminal end of FMRpolyG, which mediates the
protein’s toxic effect (Sellier et al., 2017), is identical in both non-
affected individuals with a normal allele and FXTAS-patients with
the CGG repeat expansion. It is the number of CGGs in the
FMR1 gene that differs. The expanded CGG repeat tract’s role
in increasing FMRpolyG levels, and thus amount of the toxic
C-terminus, may therefore be an important factor in triggering
the FXTAS pathogenesis. It is worth noting that lamin ring
disruption and cell death are also observed in both an episome
based cellular model system and upon transient transfection of
cultured neuronal cells, where only the first part of FMRpolyG’s
C-terminal sequence is present (Arocena et al., 2005; Hoem
et al., 2011). Thus, even though FMRpolyG expression is toxic,
it appears that the protein’s very C-terminal end is not required
for lamin ring disruption or reduction of cell viability. Further
studies are needed to determine the exact C-terminal sequence
mediating these effects.
In addition to toxicity, our study has revealed that FMRpolyG
has capability to induce formation of protein aggregates, without
the presence of CGG mRNA. We observed both nuclear
and cytoplasmic aggregates. While cytoplasmic aggregates are
prevalent in a Drosophila model of FXTAS (Jin et al., 2007),
patient material reveal inclusions exclusively in the nucleus
(Greco et al., 2002; Hunsaker et al., 2011). We therefore cannot
exclude that formation of intranuclear aggregates in patients
arise through other pathways than the aggregates observed
in this study, and in the Drosophila model. Nonetheless, our
main finding concerning aggregate formation is that presence
or absence of the CGG mRNA does not affect aggregate
formation, localization or mobility. In addition, we have applied
electron microscopy to reveal that the ultrastructure of these
aggregates is mainly filamentous, dense and non-membrane
bound. Importantly, inclusions in FXTAS patients are reported to
have similar morphological features (Greco et al., 2002; Gokden
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et al., 2009). This is to our knowledge the first study of the
ultrastructure of FMRpolyG-induced aggregates. Interestingly,
polyGlycineAlanine (poly-GA) aggregates have recently been
studied using cryoelectron tomography (Guo et al., 2018). This
dipeptide is part of a protein produced by RAN translation across
the G4C2 repeats in C9ORF72 ALS/FTD. The authors show
that poly-GA aggregates recruit the proteasomes (Guo et al.,
2018). Since the FMRpolyG aggregates stain positive for the 20S
proteasome, it is possible that the glycine in both poly-GA and
FMRpolyG aggregates interacts directly with the proteasome to
mediate this sequestration.
Finally, our study is the first to assess important features of
the FMRpolyG protein such as its mobility in different cellular
compartments and the rate and pathway for its degradation. We
show that the FMRpolyG is a stable protein, primarily degraded
through the UPS. Interestingly, a previous study has pointed out
that inhibiting the UPS leads to increased neurodegeneration in
FXTAS model systems (Oh et al., 2015). Moreover, this effect
appears to be dependent on FMRpolyG expression (Oh et al.,
2015). Our study not only supports the notion that increased
level of FMRpolyG is involved, but also provides evidence for
degradation of the FMRpolyG through the UPS. Targeting this
pathway thus appears to be an option for therapeutic intervention
that should be further explored.
In conclusion, the current study not only provides further
evidence for FMRpolyG’s possible role in causing cellular
dysregulation, but it demonstrates for the first time that
expression of the complete FMRpolyG protein, without the
presence of the CGG mRNA hairpin, is sufficient to form
aggregates and cause different features of cellular toxicity. This is
a proof of principle regarding toxicity of the FMRpolyG protein,
demonstrating that the specific CGG-repeat sequence is not
required for this effect. However, several questions regarding
FMRpolyG’s exact role in the pathogenesis of FXTAS still remain
open. Specifically, no functional domains or motifs of the
FMRpolyG protein are described, and how it mediates inhibition
of the UPS has not been elucidated. To further determine which
cellular features of FXTAS are triggered by the CGG mRNA
and the FMRpolyG, respectively, studies focusing on endogenous
expression level in patient materials are warranted. Addressing
these issues is crucial to understand the role of FMRpolyG in
the pathogenesis of FXTAS and will hopefully bring us closer to
targeted treatments.
MATERIALS AND METHODS
Cell Culture and Transfection
All cell lines were grown in DMEM (Sigma-Aldrich, D6046)
supplemented with 10% Fetal Bovine Serum (FBS) (Biochrom,
S0615) and 1% streptomycin-penicillin (Sigma-Aldrich, P4333)
at 37◦C and 5% CO2. For immunofluorescence staining and
microscopy analysis, subconfluent cells were transfected with
plasmids using Trans-IT-LT1 (Mirus, MIR2300). For flow
cytometry analyses, mRNA quantifications or immunoblotting,
cells were transfected using Metafectene Pro (Biontex, T040-
1.0). All transfections were performed according to the respective
manufacturer’s protocols.
Plasmids
The wtHP-99Gly-GFP-plasmid and a wtHP-ACG-99Gly-GFP-
plasmid (Addgene plasmid # 63091) were kind gifts from Nicolas
Charlet-Berguand (Sellier et al., 2017). The mutHP-90Gly-GFP
plasmid was made in two steps. First a modified version of
the coding sequence for the FMRpolyG protein, harboring 90
consecutive glycine codons without the CGG repeat sequence
(see sequence comparison in Supplementary Figure 1), was
ordered from Thermo Fischer Scientific. The sequence came
incorporated in a pDONR221-plasmid. Secondly, the C-terminal
GFP-tag was inserted by using the XhoI- and XbaI-sites in
both the pDONR221-plasmid and the wtHP-99Gly-GFP plasmid,
and then the entire sequence replaced the coding sequence
in the wtHP-99Gly-GFP plasmid, using the DraI or NarI,
and XbaI restriction sites. The resulting plasmid was named
mutatedHairPin-90Glycine-GFP (mutHP-90Gly-GFP). pDEST-
GFP-C1 and pDEST-eGFP-p62 have been described previously
(Lamark et al., 2003). Due to the inherent instability of the CGG-
repeats, all constructs were cut with restriction enzymes and run
on agarose gels to ensure that the CGG and GGN-repeat tracts
were not deleted or contracted. All constructs were also subject to
Sanger sequencing from both C- and N-terminal sides, to ensure




Flp-In-T-Rex 293 (HEK-FlpIn) cells (Invitrogen, R780-07) were
seeded out at approximately 25% confluency in T25 flasks
2 days prior to transfection. In FBS- and antibiotic free
medium, 0.5 µg of pcDNA5/FRT/TO- mutHP-90Gly-GFP or
pcDNA5/FRT/TO-wtHP-99Gly-GFP and 1.5 µg of pOG44 was
added, and subsequently mixed with medium containing 4 µl
of Metafectene Pro (Biontex, TO40). The mix was incubated for
20min before it was added to the cell media in T25 flasks with
HEK-FlpIn cells. After 24 h, the medium was changed to regular
DMEM with supplements, and the day after that to DMEM with
150–200µg/ml of hygromycin B (Sigm-Aldrich, 108435550019)
and 15µg/ml of blasticidin (Sigma-aldrich, SBR00022). Cells
were kept in this medium for 3–6 days, depending on the
number of viable cells, and subsequently in regular DMEM
with supplements. The cells were tested for their ability to
express the GFP-tagged protein of interest, by treatment with
1 µ/ml of doxycycline for 24–72 h followed by fluorescence
microscopy assessing the GFP-expression, and Western Blotting
to confirm that the GFP-tagged protein was of the predicted size.
Prior to all experiments, cells were maintained 1–2 weeks in
complete DMEM with 100µg/ml of hygromycin B. The FlpIn-
GFP and FlpIn GFP-p62 cell lines have been described previously
(Larsen et al., 2010).
Antibodies and Reagents
The following primary antibodies were used: guinea pig anti-
p62 (Progen, GP62-C), rabbit anti-Lamin B1 (Abcam, ab16048),
rabbit anti-20S proteasome (Enzo Life Science, PW8155), mouse
anti-γ-tubulin (Sigma-Aldrich, T6557), mouse anti-ubiquitin
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(Biomol, PW8810), rabbit anti-LC3B (Novus, NB100-2220),
rabbit anti-GFP (abcam, ab290), mouse anti-FLAG (M2) (Sigma-
Aldrich, F3165), and mouse anti-β-tubulin (Sigma-Aldrich,
T4026). Secondary antibodies used for IF were all Alexa Fluor R©
antibodies from Life Technologies: 555-conjugated goat anti-
mouse (A21424), 555-conjugated goat anti-rabbit (A21429),
555-conjugated goat anti-guinea pig (A21435), 488-conjugated
goat anti-mouse (A11029), 647-conjugated goat anti-rabbit
(A21245), 647-conjugated goat anti-guinea-pig (A21450), and
647-conjugated anti-mouse (A21236). Secondary antibodies used
for western blot were as follows: HRP-linked goat anti-rabbit
IgG (554021, BD Pharmingen), HRP-linked goat anti-mouse
IgG (554002, BD Pharmingen), Anti-biotin HRP-linked antibody
(Cell signaling, 7075P5).
Real-Time PCR
FlpIn HEK293 cells were induced to express either wtHP-
99Gly-GFP, mutHP-90Gly-GFP or GFP-C1 by adding 1µg/ml
of doxycycline for 72 h, and HEK293 cells were transfected 24 h
prior to RNA extraction using the GenElute Mammalian Total
RNA Miniprep Kit (Sigma-Aldrich). Transcriptor Universal
cDNA Master (05893151001, Roche) was used for cDNA
synthesis from total RNA. RT-PCRwas performed using FastStart
Universal SYBR Green Master (Roche) on a LightCycler 96 Real-
Time PCR System (Roche). Primers were as follows, for GFP:
5′-ACGTAAACGGCCACAAGTTC−3′ and 5′ -AAGTCGTGC
TGCTTCATGTG- 3′, for GAPDH: 5′–GGCACTGTCAAGGCT
GAAAACG−3′ and 5′- GGAGATGAGATGATACCACGCTTA
G−3′. The11Ct-method (described in Applied BiosystemsUser
Bulletin No. 2 (P/N 4303859)) was used to calculate relative
mRNA levels using GAPDH as an internal reference.
Western Blots and Immunoprecipitation
Cells were harvested in buffer containing 2% SDS, 10% glycerol,
and 50mMTris-HCl, and immediately boiled for 10min. Protein
concentration was measured using the Pierce BCA Protein
Assay Kit (Thermo Fischer Scientific # 23225). DTT (100mM)
and bromophenol blue was added to samples which were run
on a 12% SDS-polyacrylamide gel. Blotting was performed on
nitrocellulose membranes (GE Healthcare 10600003) which were
then stained with Ponceau S. Dry milk (5%) in phosphate
buffered saline with 0.1% tween-20 (PBS-T) was used for
both blocking of membranes and dilution of secondary- and
primary antibodies. Blocking was performed for 30min at
room temperature, incubation with primary antibody at 4◦C
overnight, and incubation with secondary antibody for 1 h at
room temperature. Membranes were washed minimum three
times in PBS-T both before addition of secondary antibody, and
again before development using a Chemiluminicent Peroxidase
substrate kit (Sigma-Aldrich, CPS3500) and an ImageQuant LAS
4000 machine (GE Healthcare).
Immunofluorescence Staining
Cells were seeded on glass coverslips (VWR, 631-0150) coated
with fibronectin (F1141-5MG, Sigma-Aldrich) at 24–48 h prior to
transfection or induction of expression. At indicated time points
after transfection or induction of expression, cells on coverslips
were fixed in 4% formaldehyde (Merck KGaA, 1.00496.5000)
for 20min at RT and washed twice in PBS. Cells were then
permeabilized in ice cold MeOH for 9min and subjected
to blocking in 3% goat serum/PBS (GS/PBS) for 30min at
RT. This was followed by incubation with primary antibody
(diluted in 1% GS/PBS) for 90min, 5 washes in PBS, incubation
with secondary antibody (diluted in 1% GS/PBS) for 75min,
and 5 new washes in PBS before samples were stained with
DAPI (Thermo Scientific, 62248) and washed in PBS and
dH2O. Finally, the coverslips with stained cells were mounted
by use of Mowiol 4–88 (Calbiochem) mounting medium on
microscopy slides.
Flow Cytometry
For cell viability assays, cells were seeded in 6-well plates
the day before transfection with either pDEST-GFP-C1, wtHP-
99Gly-GFP, or mutHP-90Gly-GFP. Both floating and attached
cells were collected 24 h after transfection, pelleted at 2,000 g
for 5min and resuspended in 500 µl of PBS with Propidium
Iodide (PI) (Thermo Fischer, P4864) at a final concentration
of 50µg/ml. Thresholds for PI-positive and GFP-positive cells
were set by first analyzing samples with untransfected cells
in PBS without PI. For FACS analysis of protein degradation,
FlpIn HEK293 cells were treated with 1µg/ml of tetracycline
for 48 h, except for negative controls. Wells subjected to “tet-
off” treatment were washed twice in tet-free DMEM and
maintained in tet-free medium for the times indicated for
each well. The inhibitors Bafilomycin A1 (final concentration
200 nM) and MG-132 (final concentration 10µM) were added
to the indicated wells at 6 and 12 h, respectively, before flow
analysis. The above mentioned FACS analyses were performed
on a BD LSRFortessa machine (BD Biosciences) using the BD
FACSDiva software.
To assess the portion of FlipIn HEK293 cells expressing GFP-
tagged proteins, cells were seeded in T75 flasks and treated
with 1 ug/ml of tetracycline for 24 h. Cells were trypsinized
and resuspended in DMEM media immediately before analysis.
Sorting and measurement of GFP-intensity was carried out on a
BD FACSAria III Flow Cytometer and Cell sorter, using the BD
FACSDiva 8.01 Software.
Confocal Microscopy and Quantifications
For confocal microscopy a Zeiss Axio Observer.Z1 LSM780
system (Carl Zeiss Microscopy GmbH, Germany) was
used. Quantifications were performed using the Volocity
Software (PerkinElmer).
Long-Term Imaging of Live Cells
Cells were seeded in 35mm Ibidi µ-dishes (81156, Ibidi),
coated with fibronectin, 2 days before transfection. Cells were
transfected with either mutHP-90Gly-GFP or wtHP-99Gly-GFP,
and inserted into a pre-warmed BioStation IM-QCell-S2 (Nikon)
where 10–15 regions of interest were photographed every 4min
for 12–72 h. The resulting films were processed using the Volocity
software (PerkinElmer).
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Fluorescence Recovery After
Photobleaching (FRAP)
FRAP-experiments were performed 24–48 h after transient
transfection of cells. During imaging, cells were maintained
in DMEM with supplements, at 37◦C and 5% CO2. Imaging
was performed using the C-Apochromat 40X NA1.2W objective
on the Zeiss Axio Observer.Z1 LSM780 system. Using the
ZEN 2012 (black edition) software, cells were imaged every
100 msec. At least 50 pre-bleach images were taken before
bleaching with the 488-nm laser (at 100%) for 25–50 iterations.
Post-bleaching 1,000–3,000 images were captured with 100ms
intervals. For GFP-protein diffuse in the nucleus or cytoplasm,
both bleaching and measurements of recovery were performed
in circles with a diameter of 5.8µm. Due to variation in size
of aggregates, circles were individually adapted to fit the size
of the entire aggregate. Calculation of mobile fraction of the
different GFP-positive protein species, was performed using
the FRAP function in the ZEN 2012 (black edition) software.
Recovery in bleached areas was normalized to both background
and an unbleached reference region. The data was fitted to a
mono exponential model using the ZEN 2012 FRAP function.
From these calculations the mobile fraction was extracted for
each bleached area. For all GFP-tagged proteins, analysis of a
minimum of 8 areas with diffuse GFP-protein in the nucleus,
12 with diffuse GFP-protein in the cytoplasm, and 12 GFP-
positive aggregates from more than three experiments were
combined to create averages and standard deviation (SD) of
mobile fractions.
Correlative Light and Electron
Microscopy (CLEM)
Cells were seeded on glass-bottom dishes (Mattek cat. no.
P35G-1.5-14-CGRD) with an engraved grid pattern to permit
correlation of dish coordinates between light microscope images
and the resin block face prior to ultramicrotomy. Cells were
transfected with wtHP-99Gly-GFP or mutHP-90Gly-GFP 2
days after seeding, as previously described. The day after
transfection, cells were fixed in pre-warmed (37◦C) fixative
containing 4% formaldehyde, 0.5% glutaraldehyde, and 0.05%
malachite green in PHEM buffer (60mM PIPES, 25mM
HEPES, 10mM EGTA, 4mM MgSO4·7H2O) using a microwave
processor (Ted Pella, Inc.). Cells were then imaged by confocal
microscopy as previously described. After confocal microscopy,
cells were further microwave-processed using additional fixatives
and contrast agents for electron microscopy: 1% osmium
tetroxide/0.8% K3Fe(CN)6 in PHEM buffer, 1% tannic acid in
ddH2O, and 1% uranyl acetate in ddH2O. Finally, samples
went through stepwise ethanol dehydration (30-60-96-100%)
and embedding in EPON resin. The resin was polymerized at
60◦C for 48 h and then trimmed to the relevant dish coordinate.
Seventy nanometer serial sections were cut using a diamond
knife (Diatome) on a Reichert Ultracut S ultramicrotome (Leica)
and picked up on formvar-coated slot grids. Sections were
imaged using a JEM-1010 transmission electron microscope
(JEOL) equipped with aMorada CCD camera and iTEM software
(Olympus). Subsequent image processing (stitching, overlay, etc.)
was performed using Photoshop (Adobe).
For electron tomography of CLEM-samples we prepared
sections of 200 nm that were placed on formvar-coated slot grids
and incubated with 10 nm protein A-gold on both sides (2min
each) as fiducials. Dual-axes tilt series were obtained in a Thermo
ScientificTM TalosTM F200C microscope at 200 kV, with image
series taken at tilt angles from −60 and 60 and 2◦ increment
with pixel size of 0.84 nm. Images were recorded with a Ceta
16M camera and tomograms reconstructed by weighted back
projection using IMOD software (version 4.9). The software was
also used for movie montage and final movie clips were generated
using Fiji software.
Statistics
All experiments were repeated at least three times, unless
otherwise specified. Error bars represent the standard deviation,
and two-sided Student t-tests were performed to assess
significant differences between populations. Replicates were not
pooled for statistical analyses. One star (∗) denotes P < 0.05, two
stars (∗∗) P < 0.01, and three stars (∗∗∗) P < 0.001.
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